- Oral presentation
- Open Access
Perioperative results of mechanical valve implantantation in patients with acquired valve disease
© Konstanty-Kalandyk et al; licensee BioMed Central Ltd. 2013
- Published: 11 September 2013
- Aortic Valve
- Mitral Valve
- Chronic Heart Failure
- Aortic Stenosis
- Aortic Regurgitation
The implantation of an mechanical valve in many cases remains the best treatment option for acquired valve disease. Mechanical valves, despite necessity of chronic anticoagulation, has excellent durability and favorable hemodynamic parameters. The aim of our study was to evaluate the perioperative mortality in patients undergoing implantation of a mechanical valve and identifying risk factors of death.
patients underwent mechanical valve replacement. The analysis included 960 after aortic (AVR), 455 mitral (MVR) valve surgery. Mean age in AVR was 58.7 ± 13.0 years and 59.4 ± 9.0 years in MVR. Over 70 years of life in AVR was 22% and 13% in MVR.
After mechanical aortic valve perioperative mortality was 1.95% (stenosis - 1.9%, insufficiency - 2.4%) and after mechanical mitral valve was 1.97% (stenosis - 1.6%, insufficiency- 2.75%). Mortality in the age groups <50 years, 50-60 years, 60-70 years and > 70 years amounted for mechanical aortic valve 1.6%, 1.0%, 1.7% and 3.2% and for mechanical mitral valve 1, 8%, 2.8%, 1.8% and 0% respectively. In patients with aortic stenosis greatest mortality was observed after 70 years (3.0%), similarly in aortic regurgitation (> 70 years - 8.3%). In patients with mitral stenosis greatest mortality was observed in the group <50 years (2.9%) and in the case of regurgitation greatest mortality was observed in group aged 50-60 years (6.6%). Risk factor for mortality in patients undergoing implantation of a mechanical aortic valve was age, severity of symptoms (NYHA), and chronic lung disease, and mechanical mitral valve - symptoms (NYHA) and chronic heart failure.
Implantation of artificial aortic or mitral valve is associated with a low risk of perioperative death. In the case of the aortic valve mortality mainly grows with the age of the patient and in the case of the mitral valve depends on the development and severity of symptoms of cardiac failure.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.